Literature DB >> 16212812

Neural stem cell migration toward gliomas in vitro.

Oliver Heese1, Andreas Disko, Dorothea Zirkel, Manfred Westphal, Katrin Lamszus.   

Abstract

Various in vivo studies demonstrated a migration tendency of neural stem cells (NSCs) toward gliomas, making these cells a potential carrier for delivery of therapeutic genes to disseminated glioma cells. We analyzed which factors determine NSC migration and invasion in vitro. Conditioned media prepared from 10 different human glioma cell lines, as well as 13 different tumor-associated growth factors, were analyzed for their chemotactic effects on murine C17.2 NSCs. The growth factor receptor status was analyzed by reverse transcriptase-polymerase chain reaction. Invasion of NSCs into multicellular tumor spheroids generated from 10 glioma cell lines was quantified. NSCs displayed a heterogeneous migration pattern toward glioma spheroids as well as toward glioma-cell-conditioned medium. Chemotactic migration was stimulated up to fivefold by conditioned medium as compared to controls. In coculture assays, NSC invasion varied from single cell invasion into glioma spheroids to complete dissemination of NSCs into glioma spheroids of different cell lines. Among 13 different growth factors, scatter factor/hepatocyte growth factor (SF/HGF) was the most powerful chemoattractant for NSCs, inducing a 2.5-fold migration stimulation. An antibody against SF/HGF inhibited migratory stimulation induced by conditioned media. NSC migration can be stimulated by various growth factors, similar to glioma cell migration. The extent to which NSCs infiltrate three-dimensional glioma cell aggregates appears to depend on additional factors, which are likely to include cell-to-cell contacts and interaction with extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212812      PMCID: PMC1871728          DOI: 10.1215/S1152851704000754

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  24 in total

1.  Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS.

Authors:  A Villa; E Y Snyder; A Vescovi; A Martínez-Serrano
Journal:  Exp Neurol       Date:  2000-01       Impact factor: 5.330

2.  Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS.

Authors:  Carrie B Hurelbrink; Richard J E Armstrong; Stephen B Dunnett; Anne E Rosser; Roger A Barker
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

Review 3.  Global gene and cell replacement strategies via stem cells.

Authors:  K I Park; J Ourednik; V Ourednik; R M Taylor; K S Aboody; K I Auguste; M B Lachyankar; D E Redmond; E Y Snyder
Journal:  Gene Ther       Date:  2002-05       Impact factor: 5.250

4.  A simplified method for production and growth of multicellular tumor spheroids.

Authors:  J M Yuhas; A P Li; A O Martinez; A J Ladman
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

Review 5.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  Gene therapy of experimental brain tumors using neural progenitor cells.

Authors:  S Benedetti; B Pirola; B Pollo; L Magrassi; M G Bruzzone; D Rigamonti; R Galli; S Selleri; F Di Meco; C De Fraja; A Vescovi; E Cattaneo; G Finocchiaro
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

7.  The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.

Authors:  Moneeb Ehtesham; Peter Kabos; Andrea Kabosova; Toomas Neuman; Keith L Black; John S Yu
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

8.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.

Authors:  K S Aboody; A Brown; N G Rainov; K A Bower; S Liu; W Yang; J E Small; U Herrlinger; V Ourednik; P M Black; X O Breakefield; E Y Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

9.  TrkC overexpression enhances survival and migration of neural stem cell transplants in the rat spinal cord.

Authors:  Daniel A Castellanos; Pantelis Tsoulfas; Beata R Frydel; Shyam Gajavelli; Jean-Claude Bes; Jacqueline Sagen
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

10.  Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors.

Authors:  Marc-Alexander Brockmann; Ulrike Ulbricht; Katrin Grüner; Regina Fillbrandt; Manfred Westphal; Katrin Lamszus
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

View more
  29 in total

Review 1.  Migration and fate of therapeutic stem cells in different brain disease models.

Authors:  B J Carney; K Shah
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

Review 2.  Neural stem cell therapy for cancer.

Authors:  Juli Rodriguez Bagó; Kevin T Sheets; Shawn D Hingtgen
Journal:  Methods       Date:  2015-08-24       Impact factor: 3.608

Review 3.  Role of membrane potential in the regulation of cell proliferation and differentiation.

Authors:  Sarah Sundelacruz; Michael Levin; David L Kaplan
Journal:  Stem Cell Rev Rep       Date:  2009-06-27       Impact factor: 5.739

4.  A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.

Authors:  Atique U Ahmed; Matthew A Tyler; Bart Thaci; Nikita G Alexiades; Yu Han; Ilya V Ulasov; Maciej S Lesniak
Journal:  Mol Pharm       Date:  2011-06-30       Impact factor: 4.939

5.  Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis.

Authors:  Stacey M Cromer Berman; C Joanne Wang; Inema Orukari; Andre Levchenko; Jeff W M Bulte; Piotr Walczak
Journal:  Magn Reson Med       Date:  2012-02-28       Impact factor: 4.668

6.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

Review 7.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

8.  In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.

Authors:  Mahmud Uzzaman; Gordon Keller; Isabelle M Germano
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

9.  Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells.

Authors:  Sebastian Vogel; Thorsten Trapp; Verena Börger; Corinna Peters; Dalila Lakbir; Dagmar Dilloo; Rüdiger V Sorg
Journal:  Cell Mol Life Sci       Date:  2009-11-03       Impact factor: 9.261

10.  Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.

Authors:  Mya S Thu; Joseph Najbauer; Stephen E Kendall; Ira Harutyunyan; Nicole Sangalang; Margarita Gutova; Marianne Z Metz; Elizabeth Garcia; Richard T Frank; Seung U Kim; Rex A Moats; Karen S Aboody
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.